Lod, Israel

Salim Joubran

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Salim Joubran

Introduction

Salim Joubran, an accomplished inventor located in Lod, Israel, has made significant strides in the field of cancer treatment through his groundbreaking patents. With three patents to his name, Joubran's work showcases his dedication to advancing medical technologies that can have a profound impact on patient care.

Latest Patents

Salim Joubran's latest innovations involve methodologies for treating cancer that incorporate advanced biotechnology. One of his notable patents is a method of treating cancer that includes administering a polyplex of double-stranded RNA and a polymeric conjugate. This conjugate consists of a linear polyethyleneimine covalently linked to multiple polyethylene glycol (PEG) moieties, each conjugated via a linker to a targeting moiety that binds to specific cancer antigens. These exemplary antigens comprise epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and prostate surface membrane antigen (PSMA). Such innovative strategies leverage the body's biological mechanisms to combat cancer more effectively.

Career Highlights

Throughout his career, Joubran has demonstrated an exceptional commitment to research and innovation in the biotech sector. His role at Targimmune Therapeutics AG has allowed him to collaborate with some of the brightest minds in the industry, further driving the development of sophisticated therapeutic approaches. His patents reflect a fusion of scientific knowledge and practical application, underlining his status as a leader in pharmaceutical innovations.

Collaborations

Salim Joubran has collaborated with notable colleagues, including Alex Levitzki and Alexei Shir. These partnerships not only enhance his inventions but also contribute to a collaborative environment that fosters innovation. Working alongside these esteemed professionals, Joubran continues to explore new avenues in cancer treatment research.

Conclusion

In conclusion, Salim Joubran's contributions to cancer treatment through his patented methodologies stand as a testament to his ingenuity and commitment to improving healthcare. His pioneering spirit and dedication to advancing biotechnological solutions are anticipated to result in significant breakthroughs that will benefit many patients across the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…